Author

Conway Xu

Observed name: Xu, Conway

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5000103322

R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond

2023 · Conway Xu, Allison E. Garda, et al. · Current Treatment Options in Oncology · 5

Real-world outcomes of neoadjuvant chemotherapy for advanced ovarian cancer: What happens to patients who never undergo surgery?

2025 · Kelly H. Bruce, Conway Xu, et al. · Gynecologic Oncology · 4

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma

2025 · Xiaonan Hou, Valentina Zanfagnin, et al. · Journal of Experimental & Clinical Cancer Research · 1

Abstract #42: Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: What happens to patients who never undergo surgery?

2024 · Kelly Bruce, Conway Xu, et al. · Gynecologic Oncology Reports · 1

Prognostic utility of chemotherapy response score (CRS) and CA-125 ELIMination rate constant K (KELIM) in high-grade serous ovarian cancer treated with neoadjuvant platinum-based chemotherapy

2026 · Guleid Hussein, Conway Xu, et al. · Gynecologic Oncology

937 Residual Disease and Chemotherapy Response Score (CRS) in Interval Cytoreductive Surgery (ICS) After Neoadjuvant Chemotherapy (NACT) for High-Grade Serous Ovarian Carcinoma (HGSOC): Time to Refine the Prognostic Stratification?

2026 · Mitra Abdollahi Neisani, Negar Taheri, et al. · Laboratory Investigation

Management of significant pleural effusion at ovarian cancer diagnosis: Outcomes of triage to neoadjuvant chemotherapy without thoracic assessment

2025 · Stuart A. Ostby, Chiara Ainio, et al. · Gynecologic Oncology Reports

Management of significant pleural effusion at first ovarian cancer consultation: Outcomes of whole cohort triage to neoadjuvant chemotherapy without thoracic debulking, 2016–2021

2025 · Stuart Ostby, Chiara Ainio, et al. · Gynecologic Oncology

Evaluating pegylated SN38 (PLX38A) and rucaparib in TP53 wild-type endometrial cancer.

2025 · Mikayla Brennan, Saravut John Weroha, et al. · Journal of Clinical Oncology

PR045/#233 Rucaparib plus SN38 in serous endometrial cancer

2023 · Conway Xu, Xiaonan Hou, et al. · International Journal of Gynecological Cancer

Abstract 5495: Combination therapy with poly (ADP-ribose) polymerase inhibitor in endometrial cancer

2023 · Conway Xu, Xiaonan Hou, et al. · Cancer Research

Works count: 13

Citation count: 11

H-index: 2

I10-index: